To make 5G a reality, sensing, computing and communications must transform wireless networks into intelligent, efficient and flexible drivers of a world where “every day things get connected for a smarter tomorrow.”
In recognition of the Institutional Research and Academic Career Development Award (IRACDA) program at the University of California San Diego, which provides mentored training to postdocs in biomedical sciences, the National Institutes of Health has renewed its grant funding, lengthened the term and increased the number of supported postdoctoral scholars.
In an effort to expand the number of cancer gene mutations that can be specifically targeted with personalized therapies, researchers at University of California San Diego School of Medicine and Moores Cancer Center looked for combinations of mutated genes and drugs that together kill cancer cells. The study, published July 21 in Molecular Cell, uncovered 172 new combinations that could form the basis for future cancer therapies.
Professor Emeritus Stanford S. “Sol” Penner, one of the founders and creators of the engineering program at the University of California San Diego, passed away on July 15, 2016 at his home in La Jolla, Calif. He was 95 years old.
Researchers at the University of California San Diego and the Massachusetts Institute of Technology (MIT) have come up with a strategy for using synthetic biology in therapeutics. The team engineered a clinically relevant bacterium to produce cancer drugs and then self-destruct and release the drugs at the site of tumors. The approach enables continual production and release of drugs at disease sites in mice while simultaneously limiting the size, over time, of the populations of bacteria engineered to produce the drugs.
You have to fundamentally move the needle, said Daniel Kaufman (UC San Diego B.A. ‘84) about the kinds of projects he oversees as director of Google’s Advanced Technology and Projects group (ATAP).
Keep up with all the latest from UC San Diego. Subscribe to the newsletter today.
